Skip to main content

Table 4 Budgetary impact results (€, 2010)

From: Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain

   Scenario without B/N combination Scenario with B/N combination Difference (€) with B/N vs. without B/N
1st year MAW 1,724,290 2,312,217 587,927
  HTP 28,428,367 28,541,622 113,255
  LITP 55,613,472 55,735,372 121,900
2 nd year MAW 1,711,926 2,416,973 705,047
  HTP 22,380,263 22,181,969 -198,294
  LITP 55,763,283 55,799,317 36,034
3 rd year MAW 1,747,500 2,642,079 894,579
  HTP 20,796,602 20,476,162 -320,440
  LITP 56,593,400 56,590,723 -2,677